Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Future oncology (London, England)
DOIs	https://doi.org/10.2217/fon-2023-0468
Publication status	Published - 25 Sept 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{b6e7bcb63f8245d1bb15bdad6f743d7b,

title = "Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer",

author = "Mairead Mcnamara and Valle, {Juan W.} and {et al.}",

year = "2023",

month = sep,

day = "25",

doi = "10.2217/fon-2023-0468",

language = "English",

journal = "Future oncology (London, England)",

issn = "1479-6694",

publisher = "Future Medicine ",

}

TY - JOUR

T1 - Plain language summary of the TOPAZ-1 study

T2 - durvalumab and chemotherapy for advanced biliary tract cancer

AU - Mcnamara, Mairead

AU - Valle, Juan W.

AU - et al.,

PY - 2023/9/25

Y1 - 2023/9/25

U2 - 10.2217/fon-2023-0468

DO - 10.2217/fon-2023-0468

M3 - Article

SN - 1479-6694

JO - Future oncology (London, England)

JF - Future oncology (London, England)

ER -